Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Onsite with OpenBiome
-
- 12 News Updates to Mark C. diff Awareness Month
- Managing Long-term Follow-up Cured Colon Cancer Brooks D. Cash, MD, FACP, FACG
- EC Approves Stelara for Crohn’s Disease
- FDA Approves Vemlidy for Chronic HBV
- FDA Clears Calprotectin Assay for Diagnosing IBD
- First Nonprofit Stool Bank Expands Reach, Research
- The Patient with Diarrhea
- Crohn’s Disease Linked to Thyroid Cancer Risk
-
- IBS Linked to Genetic Defects in Carbohydrate Digestion
- PPIs May be Linked to Fundic Gland Polyps, Gastric Cancer
- UNITI Trials Show Stelara Effective Induction, Maintenance Treatment for Crohn’s
- Diabetes Linked to Worse Outcomes in IBD
- IBD Patients on Entyvio May Have Higher Risk for Extraintestinal Manifestations vs. Anti-TNFs
- IBD Patients With IBS May Have Higher Risk for Chronic Fatigue
- Trump Presidency’s Impact on Gastroenterology Uncertain